Gujarat: Sterling Accuris Diagnostics, recognized as one of the fastest-growing chains of NABL-accredited pathology laboratories in India, has a prominent presence in Gujarat, Rajasthan, and Madhya Pradesh. The company has announced its acquisition of Gujarat & Maha Gujarat Pathology Laboratories, a prominent pathology service provider located in Ahmedabad. This acquisition is set to greatly expand Sterling Accuris’s reach throughout Ahmedabad and enhance its commitment to service excellence in the diagnostics sector.
Sterling Accuris is a robust, customer-focused brand recognized for delivering ethical and market-appropriate pathology diagnostic services. It provides reliable, accurate, and trustworthy solutions for individual patients, hospitals, and corporations. Gujarat Pathology Laboratory has been operating in Ahmedabad since 1998, offering an extensive array of diagnostic services, including Hematology, Biochemistry, Immunology, and Molecular Biology. With a network of eight laboratories and over 20 collection centers throughout Ahmedabad, it has successfully served nearly 2 million patients to date.
Mr. Rajiv Sharma, Managing Director of Sterling Accuris, said, “Gujarat Pathology Laboratory has been serving Ahmedabad for the past 27 years, with a strong presence and reputation in the market. Our acquisition of Gujarat Pathology Laboratory will enable us to serve a larger patient base in Ahmedabad by leveraging their strengths in the B2C segment. This collaboration will not only strengthen our service network but also enhance the reach and quality of diagnostic services we offer across Ahmedabad & Gujarat.”
Mr. Ankush Gupta, CEO of Sterling Accuris, said, “The diagnostic market in India is growing rapidly. According to recent research, the pathology segment is projected to grow at a CAGR of 14% between 2025 and 2030. Gujarat Pathology Laboratory is our fourth acquisition in the last two years. Acquiring Gujarat Pathology Laboratory is a strategic move that aligns with our growth vision, and I am confident this will elevate Sterling Accuris to new heights.”
Dr. Niraj Kothari, Founder, and Vishnubhai Patel, Co-Founder of Gujarat Pathology Laboratory, along with Mr. Navinbhai Patel, Founder of Maha Gujarat Pathology Laboratory, welcomed the acquisition, stating: “Sterling Accuris brings a strong and established presence in the diagnostics market, and we see this partnership as a valuable opportunity to scale our services. Gujarat Pathology has a solid foundation in Ahmedabad, and with this acquisition, we will be able to leverage the high-end technology available with Sterling Accuris. This collaboration will enable us to offer a wide range of diagnostic tests, helping us expand our reach and improve accessibility.”
Since its launch in 2015, Sterling Accuris has experienced remarkable growth, establishing a robust presence with over 75 laboratories and more than 300 collection centers throughout India. To uphold its patient-centric philosophy and enhance customer friendliness, Sterling has implemented a variety of platforms, including multilingual chatbots, engaging and user-friendly mobile applications, informative and easily navigable websites, as well as a cutting-edge customer care center featuring a dedicated single point of contact. This ensures that our diverse range of services is readily accessible to users. It is also important to mention that Morgan Stanley Private Equity Asia is an investor in Sterling Accuris Wellness Private Limited.
